Clinical Research Directory
Browse clinical research sites, groups, and studies.
68Ga-PSMA PET/MRI in Conjunction With mpMRI for Evaluating Prospective Prostate Cancer Risk
Sponsor: Chang Gung Memorial Hospital
Summary
The goal of this observational study is to learn if Ga-68 PSMA PET/MRI can better diagnose prostate cancer than mpMRI in males between 40 to 85 years old who is naive to prostate biopsy and is suspicious for prostate cancer by elevated PSA or lower urinary tract symptoms. The main questions it aims to answer are: 1. Does PSMA PET/MRI have better PPV and NPV than mpMRI to diagnose prostate cancer? 2. Does lesion location concordance in PSMA PET and MRI effect diagnosis accuracy? Participants will: 1. Undergo a Ga-68 PSMA PET/MRI scan and keep followed up for 2 years to check if prostate cancer is diagnosed after the scan. 2. Between the follow-up period, visit the clinic once every 6 months for checkups and blood tests.
Official title: Utilizing 68Ga-PSMA PET/MRI Imaging in Conjunction With mpMRI for Evaluating Prospective Prostate Cancer Risk
Key Details
Gender
MALE
Age Range
40 Years - 85 Years
Study Type
OBSERVATIONAL
Enrollment
71
Start Date
2024-07-01
Completion Date
2027-05-31
Last Updated
2024-07-10
Healthy Volunteers
Yes
Conditions
Interventions
Ga-68 PSMA PET/MRI
The participant will undergo a Ga-68 PSMA PET/MRI scan, and then be followed up for 2 years to see if prostate cancer is diagnosed.
Locations (1)
Chang Gung Memorial Hospital ,Linkou
Taoyuan, Taiwan